 | | 7D4 | | Name: | [[(2~{S},3~{R},4~{R})-4-(6-aminopurin-9-yl)-3-(hydroxymethyl)oxetan-2-yl]methoxy-oxidanyl-phosphoryl] phosphono hydrogen phosphate | | Formula: | C10 H16 N5 O12 P3 | | SMILES: | Nc1ncnc2n(cnc12)[CH]3O[CH](CO[P](O)(=O)O[P](O)(=O)O[P](O)(O)=O)[CH]3CO | | InChi: | InChI=1S/C10H16N5O12P3/c11-8-7-9(13-3-12-8)15(4-14-7)10-5(1-16)6(25-10)2-24-29(20,21)27-30(22,23)26-28(17,18)19/h3-6,10,16H,1-2H2,(H,20,21)(H,22,23)(H2,11,12,13)(H2,17,18,19)/t5-,6-,10-/m1/s1 | | Synonyms: | oxetanocin A triphosphate | | Definition date: | 2016-10-07 | | Last modified: | 2021-03-01 | | Release date: | 2016-11-16 | | Identifier: | [[(2~{S},3~{R},4~{R})-4-(6-aminopurin-9-yl)-3-(hydroxymethyl)oxetan-2-yl]methoxy-oxidanyl-phosphoryl] phosphono hydrogen phosphate |
|
 | | 7D5 | | Name: | [(2S,3R,4R)-4-(6-amino-9H-purin-9-yl)-3-(hydroxymethyl)oxetan-2-yl]methyl dihydrogen phosphate | | Formula: | C10 H14 N5 O6 P | | SMILES: | c1nc(c2c(n1)n(cn2)C3C(C(COP(O)(=O)O)O3)CO)N | | InChi: | InChI=1S/C10H14N5O6P/c11-8-7-9(13-3-12-8)15(4-14-7)10-5(1-16)6(21-10)2-20-22(17,18)19/h3-6,10,16H,1-2H2,(H2,11,12,13)(H2,17,18,19)/t5-,6-,10-/m1/s1 | | Synonyms: | oxetanocin A monophosphate | | Definition date: | 2016-10-07 | | Last modified: | 2021-03-01 | | Release date: | 2016-11-16 | | Identifier: | [(2S,3R,4R)-4-(6-amino-9H-purin-9-yl)-3-(hydroxymethyl)oxetan-2-yl]methyl dihydrogen phosphate |
|
 | | 7DP | | Name: | ~{N}-[2-[3,4-bis(oxidanyl)phenyl]ethyl]ethanamide | | Formula: | C10 H13 N O3 | | SMILES: | CC(=O)NCCc1ccc(O)c(O)c1 | | InChi: | InChI=1S/C10H13NO3/c1-7(12)11-5-4-8-2-3-9(13)10(14)6-8/h2-3,6,13-14H,4-5H2,1H3,(H,11,12) | | Synonyms: | N-acetyldopamine | | Definition date: | 2016-06-24 | | Last modified: | 2021-03-01 | | Release date: | 2017-07-05 | | Identifier: | ~{N}-[2-[3,4-bis(oxidanyl)phenyl]ethyl]ethanamide |
|
 | | LKP | | Name: | trans-4-{(1R)-2-[(5S)-6-fluoro-5H-imidazo[5,1-a]isoindol-5-yl]-1-hydroxyethyl}cyclohexan-1-ol | | Formula: | C18 H21 F N2 O2 | | SMILES: | c23C(CC(O)C1CCC(CC1)O)n4c(c2cccc3F)cnc4 | | InChi: | InChI=1S/C18H21FN2O2/c19-14-3-1-2-13-16-9-20-10-21(16)15(18(13)14)8-17(23)11-4-6-12(22)7-5-11/h1-3,9-12,15,17,22-23H,4-8H2/t11-,12-,15-,17+/m0/s1 | | Synonyms: | Navoximod | | Definition date: | 2019-02-27 | | Last modified: | 2021-03-01 | | Release date: | 2019-07-17 | | Identifier: | trans-4-{(1R)-2-[(5S)-6-fluoro-5H-imidazo[5,1-a]isoindol-5-yl]-1-hydroxyethyl}cyclohexan-1-ol |
|
 | | LLO | | Name: | N~6~-[(1S)-3-hydroxy-1,3-dimethylbutyl]-L-lysine | | Formula: | C12 H26 N2 O3 | | SMILES: | O=C(O)C(N)CCCCNC(CC(O)(C)C)C | | InChi: | InChI=1S/C12H26N2O3/c1-9(8-12(2,3)17)14-7-5-4-6-10(13)11(15)16/h9-10,14,17H,4-8,13H2,1-3H3,(H,15,16)/t9-,10-/m0/s1 | | Synonyms: | 4-Hydroxy-4-Methyl-2-Pentanone | | Definition date: | 2010-07-20 | | Last modified: | 2021-03-01 | | Identifier: | N~6~-[(2S)-4-hydroxy-4-methylpentan-2-yl]-L-lysine |
|
 | | LMD | | Name: | tetradecyl 4-O-alpha-D-glucopyranosyl-beta-D-glucopyranoside | | Formula: | C26 H50 O11 | | SMILES: | O(CCCCCCCCCCCCCC)C2OC(C(OC1OC(CO)C(O)C(O)C1O)C(O)C2O)CO | | InChi: | InChI=1S/C26H50O11/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-34-25-23(33)21(31)24(18(16-28)36-25)37-26-22(32)20(30)19(29)17(15-27)35-26/h17-33H,2-16H2,1H3/t17-,18-,19-,20+,21-,22-,23-,24-,25-,26-/m1/s1 | | Synonyms: | n-Tetradecyl-b-D-maltopyranosid | | Definition date: | 2012-06-06 | | Last modified: | 2021-03-01 | | Release date: | 2012-08-24 | | Identifier: | tetradecyl 4-O-alpha-D-glucopyranosyl-beta-D-glucopyranoside |
|
 | | LMR | | Name: | (2S)-2-hydroxybutanedioic acid | | Formula: | C4 H6 O5 | | SMILES: | O=C(O)CC(O)C(=O)O | | InChi: | InChI=1S/C4H6O5/c5-2(4(8)9)1-3(6)7/h2,5H,1H2,(H,6,7)(H,8,9)/t2-/m0/s1 | | Synonyms: | L-Malate | | Definition date: | 2008-03-24 | | Last modified: | 2021-03-01 | | Identifier: | (2S)-2-hydroxybutanedioic acid |
|
 | | LN5 | | Name: | N5-(1-iminopropyl)-L-ornithine | | Formula: | C8 H17 N3 O2 | | SMILES: | O=C(O)C(N)CCCNC(=[N@H])CC | | InChi: | InChI=1S/C8H17N3O2/c1-2-7(10)11-5-3-4-6(9)8(12)13/h6H,2-5,9H2,1H3,(H2,10,11)(H,12,13)/t6-/m0/s1 | | Synonyms: | (2S)-2-azanyl-5-(propanimidoylamino)pentanoic acid | | Definition date: | 2009-07-07 | | Last modified: | 2021-03-01 | | Identifier: | N~5~-[(1Z)-propanimidoyl]-L-ornithine |
|
 | | LN6 | | Name: | N~5~-[(1E)-pentanimidoyl]-L-ornithine | | Formula: | C10 H21 N3 O2 | | SMILES: | O=C(O)C(N)CCCNC(=[N@H])CCCC | | InChi: | InChI=1S/C10H21N3O2/c1-2-3-6-9(12)13-7-4-5-8(11)10(14)15/h8H,2-7,11H2,1H3,(H2,12,13)(H,14,15)/t8-/m0/s1 | | Synonyms: | N5-(1-iminopentyl)-L-ornithine | | Definition date: | 2010-10-20 | | Last modified: | 2021-03-01 | | Identifier: | N~5~-[(1E)-pentanimidoyl]-L-ornithine |
|
 | | LNR | | Name: | L-NOREPINEPHRINE | | Formula: | C8 H11 N O3 | | SMILES: | Oc1ccc(cc1O)C(O)CN | | InChi: | InChI=1S/C8H11NO3/c9-4-8(12)5-1-2-6(10)7(11)3-5/h1-3,8,10-12H,4,9H2/t8-/m0/s1 | | Synonyms: | NORADRENALINE | | Definition date: | 2001-03-28 | | Last modified: | 2021-03-01 | | Identifier: | 4-[(1R)-2-amino-1-hydroxyethyl]benzene-1,2-diol |
|
 | | LOA | | Name: | (3beta,5beta,9beta)-3-(acetyloxy)cholan-24-oic acid | | Formula: | C26 H42 O4 | | SMILES: | O=C(O)CCC(C4C3(C(C2C(C1(CCC(OC(=O)C)CC1CC2)C)CC3)CC4)C)C | | InChi: | InChI=1S/C26H42O4/c1-16(5-10-24(28)29)21-8-9-22-20-7-6-18-15-19(30-17(2)27)11-13-25(18,3)23(20)12-14-26(21,22)4/h16,18-23H,5-15H2,1-4H3,(H,28,29)/t16-,18-,19-,20+,21-,22+,23+,25+,26-/m1/s1 | | Synonyms: | Lithocholic acid acetate | | Definition date: | 2013-02-08 | | Last modified: | 2021-03-01 | | Release date: | 2013-06-26 | | Identifier: | (3beta,5beta,9beta)-3-(acetyloxy)cholan-24-oic acid |
|
 | | LOC | | Name: | N-[(7S)-1,2,3,10-tetramethoxy-9-oxo-6,7-dihydro-5H-benzo[d]heptalen-7-yl]ethanamide | | Formula: | C22 H25 N O6 | | SMILES: | O=C(NC3C1=CC(=O)C(OC)=CC=C1c2c(cc(OC)c(OC)c2OC)CC3)C | | InChi: | InChI=1S/C22H25NO6/c1-12(24)23-16-8-6-13-10-19(27-3)21(28-4)22(29-5)20(13)14-7-9-18(26-2)17(25)11-15(14)16/h7,9-11,16H,6,8H2,1-5H3,(H,23,24)/t16-/m0/s1 | | Synonyms: | COLCHICINE | | Definition date: | 2008-08-12 | | Last modified: | 2021-03-01 | | Identifier: | N-[(7S)-1,2,3,10-tetramethoxy-9-oxo-5,6,7,9-tetrahydrobenzo[a]heptalen-7-yl]acetamide |
|
 | | LOP | | Name: | (1R)-2-{[(R)-(2-AMINOETHOXY)(HYDROXY)PHOSPHORYL]OXY}-1-[(DODECANOYLOXY)METHYL]ETHYL (9Z)-OCTADEC-9-ENOATE | | Formula: | C35 H68 N O8 P | | SMILES: | O=C(OCC(OC(=O)CCCCCCCC=C/CCCCCCCC)COP(=O)(OCCN)O)CCCCCCCCCCC | | InChi: | InChI=1S/C35H68NO8P/c1-3-5-7-9-11-13-14-15-16-17-18-20-22-24-26-28-35(38)44-33(32-43-45(39,40)42-30-29-36)31-41-34(37)27-25-23-21-19-12-10-8-6-4-2/h15-16,33H,3-14,17-32,36H2,1-2H3,(H,39,40)/b16-15-/t33-/m1/s1 | | Synonyms: | LAURYL OLEYL PHOSPHATIDYL ETHANOLAMINE | | Definition date: | 2006-02-09 | | Last modified: | 2021-03-01 | | Identifier: | (1R)-2-{[(R)-(2-aminoethoxy)(hydroxy)phosphoryl]oxy}-1-[(dodecanoyloxy)methyl]ethyl (9Z)-octadec-9-enoate |
|
 | | 7IM | | Name: | N-[(2S)-3-{[(1S)-1-carboxy-2-phenylethyl]amino}-2-methyl-3-oxopropanoyl]-L-threonyl-N-[(3S,4S)-1,3-dihydroxy-6-methylheptan-4-yl]-L-allothreoninamide | | Formula: | C29 H46 N4 O10 | | SMILES: | O=C(NC(CC(C)C)C(O)CCO)C(NC(=O)C(NC(=O)C(C(=O)NC(C(=O)O)Cc1ccccc1)C)C(O)C)C(O)C | | InChi: | InChI=1S/C29H46N4O10/c1-15(2)13-20(22(37)11-12-34)30-27(40)23(17(4)35)33-28(41)24(18(5)36)32-26(39)16(3)25(38)31-21(29(42)43)14-19-9-7-6-8-10-19/h6-10,15-18,20-24,34-37H,11-14H2,1-5H3,(H,30,40)(H,31,38)(H,32,39)(H,33,41)(H,42,43)/t16-,17+,18-,20+,21+,22+,23+,24+/m1/s1 | | Synonyms: | Macyranone-A | | Definition date: | 2015-02-10 | | Last modified: | 2021-03-01 | | Release date: | 2015-02-18 | | Identifier: | N-[(2S)-3-{[(1S)-1-carboxy-2-phenylethyl]amino}-2-methyl-3-oxopropanoyl]-L-threonyl-N-[(3S,4S)-1,3-dihydroxy-6-methylheptan-4-yl]-L-allothreoninamide |
|
 | | LPS | | Name: | O-{HYDROXY[((2R)-2-HYDROXY-3-{[(1S)-1-HYDROXYPENTADECYL]OXY}PROPYL)OXY]PHOSPHORYL}-L-SERINE | | Formula: | C21 H44 N O9 P | | SMILES: | O=C(O)C(N)COP(=O)(OCC(O)COC(O)CCCCCCCCCCCCCC)O | | InChi: | InChI=1S/C21H44NO9P/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-20(24)29-15-18(23)16-30-32(27,28)31-17-19(22)21(25)26/h18-20,23-24H,2-17,22H2,1H3,(H,25,26)(H,27,28)/t18-,19+,20-/m1/s1 | | Synonyms: | LYSOPHOSPHOTIDYLSERINE | | Definition date: | 2003-02-21 | | Last modified: | 2021-03-01 | | Identifier: | O-[(R)-hydroxy{[(2R)-2-hydroxy-3-{[(1R)-1-hydroxypentadecyl]oxy}propyl]oxy}phosphoryl]-L-serine |
|
 | | 7JD | | Name: | 6-(4-fluorophenyl)-8-oxidanyl-3~{H}-quinazolin-4-one | | Formula: | C14 H9 F N2 O2 | | SMILES: | Oc1cc(cc2C(=O)NC=Nc12)c3ccc(F)cc3 | | InChi: | InChI=1S/C14H9FN2O2/c15-10-3-1-8(2-4-10)9-5-11-13(12(18)6-9)16-7-17-14(11)19/h1-7,18H,(H,16,17,19) | | Synonyms: | 6-(4-fluorophenyl)-8-hydroxy-3H-quinazolin-4-one | | Definition date: | 2016-11-02 | | Last modified: | 2021-03-01 | | Release date: | 2017-11-22 | | Identifier: | 6-(4-fluorophenyl)-8-oxidanyl-3~{H}-quinazolin-4-one |
|
 | | LPY | | Name: | (2R)-2-hydroxy-3-{[(S)-hydroxy{[(1S,2R,3R,4S,5S,6R)-2,3,4,5,6-pentahydroxycyclohexyl]oxy}phosphoryl]oxy}propyl tridecanoate | | Formula: | C22 H43 O12 P | | SMILES: | P(OC1C(O)C(O)C(O)C(O)C1O)(O)(=O)OCC(O)COC(=O)CCCCCCCCCCCC | | InChi: | InChI=1S/C22H43O12P/c1-2-3-4-5-6-7-8-9-10-11-12-16(24)32-13-15(23)14-33-35(30,31)34-22-20(28)18(26)17(25)19(27)21(22)29/h15,17-23,25-29H,2-14H2,1H3,(H,30,31)/t15-,17-,18-,19+,20-,21-,22-/m1/s1 | | Synonyms: | sn-1-tridecanoyl-phosphatidylinositol | | Definition date: | 2015-01-22 | | Last modified: | 2021-03-01 | | Release date: | 2015-07-15 | | Identifier: | (2R)-2-hydroxy-3-{[(S)-hydroxy{[(1S,2R,3R,4S,5S,6R)-2,3,4,5,6-pentahydroxycyclohexyl]oxy}phosphoryl]oxy}propyl tridecanoate |
|
 | | 7JM | | Name: | 6-(2-methylpyridin-3-yl)-8-oxidanyl-3~{H}-quinazolin-4-one | | Formula: | C14 H11 N3 O2 | | SMILES: | Cc1ncccc1c2cc(O)c3N=CNC(=O)c3c2 | | InChi: | InChI=1S/C14H11N3O2/c1-8-10(3-2-4-15-8)9-5-11-13(12(18)6-9)16-7-17-14(11)19/h2-7,18H,1H3,(H,16,17,19) | | Synonyms: | 8-hydroxy-6-(2-methylpyridin-3-yl)-3H-quinazolin-4-one | | Definition date: | 2016-11-02 | | Last modified: | 2021-03-01 | | Release date: | 2017-11-22 | | Identifier: | 6-(2-methylpyridin-3-yl)-8-oxidanyl-3~{H}-quinazolin-4-one |
|
 | | 7JU | | Name: | 7-fluoranyl-6-(4-fluorophenyl)-8-oxidanyl-3~{H}-quinazolin-4-one | | Formula: | C14 H8 F2 N2 O2 | | SMILES: | Oc1c(F)c(cc2C(=O)NC=Nc12)c3ccc(F)cc3 | | InChi: | InChI=1S/C14H8F2N2O2/c15-8-3-1-7(2-4-8)9-5-10-12(13(19)11(9)16)17-6-18-14(10)20/h1-6,19H,(H,17,18,20) | | Synonyms: | 7-fluoro-6-(4-fluorophenyl)-8-hydroxy-3H-quinazolin-4-one | | Definition date: | 2016-11-02 | | Last modified: | 2021-03-01 | | Release date: | 2017-11-22 | | Identifier: | 7-fluoranyl-6-(4-fluorophenyl)-8-oxidanyl-3~{H}-quinazolin-4-one |
|
 | | 7JV | | Name: | 6-[2-(methoxymethyl)phenyl]-8-oxidanyl-1~{H}-quinazolin-4-one | | Formula: | C16 H14 N2 O3 | | SMILES: | COCc1ccccc1c2cc(O)c3NC=NC(=O)c3c2 | | InChi: | InChI=1S/C16H14N2O3/c1-21-8-10-4-2-3-5-12(10)11-6-13-15(14(19)7-11)17-9-18-16(13)20/h2-7,9,19H,8H2,1H3,(H,17,18,20) | | Synonyms: | 8-hydroxy-6-[2-(methoxymethyl)phenyl]-3H-quinazolin-4-one | | Definition date: | 2016-11-02 | | Last modified: | 2021-03-01 | | Release date: | 2017-11-22 | | Identifier: | 6-[2-(methoxymethyl)phenyl]-8-oxidanyl-1~{H}-quinazolin-4-one |
|
 | | LQQ | | Name: | 6-ACETYL-8-CYCLOPENTYL-5-METHYL-2-[(5-PIPERAZIN-1-YLPYRIDIN-2-YL)AMINO]PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE | | Formula: | C24 H29 N7 O2 | | SMILES: | O=C2N(c1nc(ncc1C(=C2C(=O)C)C)Nc3ncc(cc3)N4CCNCC4)C5CCCC5 | | InChi: | InChI=1S/C24H29N7O2/c1-15-19-14-27-24(28-20-8-7-18(13-26-20)30-11-9-25-10-12-30)29-22(19)31(17-5-3-4-6-17)23(33)21(15)16(2)32/h7-8,13-14,17,25H,3-6,9-12H2,1-2H3,(H,26,27,28,29) | | Synonyms: | Palbociclib | | Definition date: | 2005-11-28 | | Last modified: | 2021-03-01 | | Identifier: | 6-acetyl-8-cyclopentyl-5-methyl-2-[(5-piperazin-1-ylpyridin-2-yl)amino]pyrido[2,3-d]pyrimidin-7(8H)-one |
|
 | | LRD | | Name: | 2-[(E)-(3-chloro-4-hydroxyphenyl)(3-chloro-4-oxocyclohexa-2,5-dien-1-ylidene)methyl]benzenesulfonic acid | | Formula: | C19 H12 Cl2 O5 S | | SMILES: | ClC3=CC(=C(/c1ccc(O)c(Cl)c1)c2ccccc2S(=O)(=O)O)C=CC3=O | | InChi: | InChI=1S/C19H12Cl2O5S/c20-14-9-11(5-7-16(14)22)19(12-6-8-17(23)15(21)10-12)13-3-1-2-4-18(13)27(24,25)26/h1-10,22H,(H,24,25,26)/b19-12+ | | Synonyms: | Chlorophenol Red | | Definition date: | 2013-10-23 | | Last modified: | 2021-03-01 | | Release date: | 2013-10-30 | | Identifier: | 2-[(E)-(3-chloro-4-hydroxyphenyl)(3-chloro-4-oxocyclohexa-2,5-dien-1-ylidene)methyl]benzenesulfonic acid |
|
 | | LSN | | Name: | [2-butyl-5-chloranyl-3-[[4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol | | Formula: | C22 H23 Cl N6 O | | SMILES: | CCCCc1nc(Cl)c(CO)n1Cc2ccc(cc2)c3ccccc3c4n[nH]nn4 | | InChi: | InChI=1S/C22H23ClN6O/c1-2-3-8-20-24-21(23)19(14-30)29(20)13-15-9-11-16(12-10-15)17-6-4-5-7-18(17)22-25-27-28-26-22/h4-7,9-12,30H,2-3,8,13-14H2,1H3,(H,25,26,27,28) | | Synonyms: | Losartan | | Definition date: | 2017-02-01 | | Last modified: | 2021-03-01 | | Release date: | 2017-10-25 | | Identifier: | [2-butyl-5-chloranyl-3-[[4-[2-(2~{H}-1,2,3,4-tetrazol-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol |
|
 | | LSP | | Name: | (7S)-4,7-DIHYDROXY-10-OXO-3,5,9-TRIOXA-4-PHOSPHAUNDECAN-1-AMINIUM 4-OXIDE | | Formula: | C7 H17 N O7 P | | SMILES: | O=C(OCC(O)COP(=O)(OCC[NH3+])O)C | | InChi: | InChI=1S/C7H16NO7P/c1-6(9)13-4-7(10)5-15-16(11,12)14-3-2-8/h7,10H,2-5,8H2,1H3,(H,11,12)/p+1/t7-/m0/s1 | | Synonyms: | 1-ACETYL-2-LYSO-SN-GLYCERO-3-PHOSPHOETHANOLAMINE | | Definition date: | 2006-02-01 | | Last modified: | 2021-03-01 | | Identifier: | (4S,7S)-4,7-dihydroxy-10-oxo-3,5,9-trioxa-4-phosphaundecan-1-aminium 4-oxide |
|
 | | LSS | | Name: | 5'-O-(L-leucylsulfamoyl)adenosine | | Formula: | C16 H25 N7 O7 S | | SMILES: | O=C(NS(=O)(=O)OCC3OC(n2cnc1c(ncnc12)N)C(O)C3O)C(N)CC(C)C | | InChi: | InChI=1S/C16H25N7O7S/c1-7(2)3-8(17)15(26)22-31(27,28)29-4-9-11(24)12(25)16(30-9)23-6-21-10-13(18)19-5-20-14(10)23/h5-9,11-12,16,24-25H,3-4,17H2,1-2H3,(H,22,26)(H2,18,19,20)/t8-,9+,11+,12+,16+/m0/s1 | | Synonyms: | 5-O-N-LEUCYL-SULFAMOYLADENOSINE | | Definition date: | 2013-01-11 | | Last modified: | 2021-03-01 | | Release date: | 2013-02-22 | | Identifier: | 5'-O-(L-leucylsulfamoyl)adenosine |
|
